Reuters logo
4 years ago
BRIEF-Lundbeck, Otsuka start trials for alzheimer drug
October 10, 2013 / 7:21 AM / 4 years ago

BRIEF-Lundbeck, Otsuka start trials for alzheimer drug

1 Min Read

COPENHAGEN, Oct 10 (Reuters) - Danish pharmaceutical group H.Lundbeck and its Japanese parther Otsuka Pharmaceutical Co., Ltd. said in a statement on Thursday: * Companies to initiate the first of four phase III clinical trials on compound Lu AE58054 as a new add-on treatment for alzheimer's disease.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below